CHARACTERIZATION OF CISPLATIN-RESISTANT COLO-316 HUMAN OVARIAN-CARCINOMA CELLS

[1] ENHANCED POTENTIATION OF CISPLATIN CYTO-TOXICITY IN HUMAN OVARIAN-CARCINOMA CELLS BY PROLONGED GLUTATHIONE DEPLETION [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 1988, 65 (01) : 51 - 58

[2] ANDREWS PA, 1985, CANCER RES, V45, P6250

[3] ANDREWS PA, 1986, MOL PHARMACOL, V30, P643

[4] ANDREWS PA, 1988, CANCER RES, V48, P68

[5] ANDREWS PA, 1986, P AM ASSOC CANC RES, V27, P289

[6] BEHRENS BC, 1987, CANCER RES, V47, P414

[7] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3

[8] CARRIER-DEPENDENT AND CARRIER-INDEPENDENT TRANSPORT OF ANTICANCER ALKYLATING-AGENTS [J]. NATURE, 1981, 294 (5838) : 281 - 283

[9] DORNISH JM, 1986, ANTICANCER RES, V6, P583

[10] GALE GR, 1973, CANCER RES, V33, P813

[1] ENHANCED POTENTIATION OF CISPLATIN CYTO-TOXICITY IN HUMAN OVARIAN-CARCINOMA CELLS BY PROLONGED GLUTATHIONE DEPLETION [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 1988, 65 (01) : 51 - 58

[2] ANDREWS PA, 1985, CANCER RES, V45, P6250

[3] ANDREWS PA, 1986, MOL PHARMACOL, V30, P643

[4] ANDREWS PA, 1988, CANCER RES, V48, P68

[5] ANDREWS PA, 1986, P AM ASSOC CANC RES, V27, P289

[6] BEHRENS BC, 1987, CANCER RES, V47, P414

[7] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3

[8] CARRIER-DEPENDENT AND CARRIER-INDEPENDENT TRANSPORT OF ANTICANCER ALKYLATING-AGENTS [J]. NATURE, 1981, 294 (5838) : 281 - 283

[9] DORNISH JM, 1986, ANTICANCER RES, V6, P583

[10] GALE GR, 1973, CANCER RES, V33, P813